These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 9218427)

  • 1. The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific.
    Lyon M; Rushton G; Gallagher JT
    J Biol Chem; 1997 Jul; 272(29):18000-6. PubMed ID: 9218427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
    Loo BM; Kreuger J; Jalkanen M; Lindahl U; Salmivirta M
    J Biol Chem; 2001 May; 276(20):16868-76. PubMed ID: 11278860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factor-binding sequence in human alpha2-macroglobulin targets the receptor-binding site in transforming growth factor-beta.
    Arandjelovic S; Freed TA; Gonias SL
    Biochemistry; 2003 May; 42(20):6121-7. PubMed ID: 12755614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix.
    Lipscombe RJ; Nakhoul AM; Sanderson CJ; Coombe DR
    J Leukoc Biol; 1998 Mar; 63(3):342-50. PubMed ID: 9500522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants.
    Lyon M; Deakin JA; Mizuno K; Nakamura T; Gallagher JT
    J Biol Chem; 1994 Apr; 269(15):11216-23. PubMed ID: 8157651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin/heparan sulphate binding in the TGF-beta cytokine superfamily.
    Rider CC
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):458-60. PubMed ID: 16709187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library.
    Ashikari-Hada S; Habuchi H; Kariya Y; Itoh N; Reddi AH; Kimata K
    J Biol Chem; 2004 Mar; 279(13):12346-54. PubMed ID: 14707131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.
    Casu B; Naggi A; Torri G
    Matrix Biol; 2010 Jul; 29(6):442-52. PubMed ID: 20416374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase.
    Robinson CJ; Mulloy B; Gallagher JT; Stringer SE
    J Biol Chem; 2006 Jan; 281(3):1731-40. PubMed ID: 16258170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The malaria circumsporozoite protein: interaction of the conserved regions I and II-plus with heparin-like oligosaccharides in heparan sulfate.
    Ying P; Shakibaei M; Patankar MS; Clavijo P; Beavis RC; Clark GF; Frevert U
    Exp Parasitol; 1997 Feb; 85(2):168-82. PubMed ID: 9030667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the molecule.
    Qian SW; Burmester JK; Tsang ML; Weatherbee JA; Hinck AP; Ohlsen DJ; Sporn MB; Roberts AB
    J Biol Chem; 1996 Nov; 271(48):30656-62. PubMed ID: 8940041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin and heparan sulfate bind interleukin-10 and modulate its activity.
    Salek-Ardakani S; Arrand JR; Shaw D; Mackett M
    Blood; 2000 Sep; 96(5):1879-88. PubMed ID: 10961890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular heparan sulfate negatively modulates transforming growth factor-beta1 (TGF-beta1) responsiveness in epithelial cells.
    Chen CL; Huang SS; Huang JS
    J Biol Chem; 2006 Apr; 281(17):11506-14. PubMed ID: 16492675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural determinants of heparin-transforming growth factor-β1 interactions and their effects on signaling.
    Lee J; Wee S; Gunaratne J; Chua RJ; Smith RA; Ling L; Fernig DG; Swaminathan K; Nurcombe V; Cool SM
    Glycobiology; 2015 Dec; 25(12):1491-504. PubMed ID: 26306634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of the binding site for transforming growth factor-beta in human alpha2-macroglobulin to a 20-kDa peptide that also contains the bait region.
    Webb DJ; Wen J; Karns LR; Kurilla MG; Gonias SL
    J Biol Chem; 1998 May; 273(21):13339-46. PubMed ID: 9582381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogenic activity of acidic fibroblast growth factor is enhanced by highly sulfated oligosaccharides derived from heparin and heparan sulfate.
    Gambarini AG; Miyamoto CA; Lima GA; Nader HB; Dietrich CP
    Mol Cell Biochem; 1993 Jul; 124(2):121-9. PubMed ID: 7694075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis and identification of the Grem2 heparin/heparan sulfate-binding motif.
    Kattamuri C; Nolan K; Thompson TB
    Biochem J; 2017 Mar; 474(7):1093-1107. PubMed ID: 28104757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding of human betacellulin to heparin, heparan sulfate and related polysaccharides.
    Mummery RS; Mulloy B; Rider CC
    Glycobiology; 2007 Oct; 17(10):1094-103. PubMed ID: 17673511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling: role of divalent cations.
    Ricard-Blum S; Féraud O; Lortat-Jacob H; Rencurosi A; Fukai N; Dkhissi F; Vittet D; Imberty A; Olsen BR; van der Rest M
    J Biol Chem; 2004 Jan; 279(4):2927-36. PubMed ID: 14585835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin.
    Sasaki T; Larsson H; Kreuger J; Salmivirta M; Claesson-Welsh L; Lindahl U; Hohenester E; Timpl R
    EMBO J; 1999 Nov; 18(22):6240-8. PubMed ID: 10562536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.